| Name | Title | Contact Details |
|---|
RxWiki Inc. is a rapidly growing Digital Health company connecting pharmacies and patients through its Digital Pharmacist (www.digitalpharmacist.com) SaaS platform and original Pharmacist written and verified content. RxWiki`s Digital Pharmacist platform powers the websites and mobile applications of 1,300 specialty and community pharmacy brands. Patients can manage their medications, complete digital refills and engage with medication adherence programs. RxWiki`s original Pharmacist written and verified content includes 20,000 original health articles, 7,500 health-related videos, and 100 disease condition channels. More than 3,700 community pharmacies and national health brands, like Health Mart and Health Media Network, license this content to engage and educate their patients. The company is headquartered in Austin, Texas.
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
ClearTrial, LLC is a Westmont, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saratoga Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Saratoga Hospital is based in Saratoga Springs, NY. You can find more information on Saratoga Hospital at www.saratogacare.org
Unlock Health Chiropractic is a natural medical service provider that offers long term solutions and overall wellness for families.